Introduction
One of the predominant regulators in the promotion of normal mammary epithelial proliferation and breast cancer is 17b-estradiol (E2) and its receptors, estrogen receptor a and b (ERa and b). Significant progress in elucidating the molecular mechanism of estrogen receptor function has been achieved with the detailed characterization of the receptor-ligand interaction as well as identifying the various signaling molecules that associate with the receptor. The biological importance of ERa was demonstrated with the generation of the estrogen receptor a knockout (ERKOa) mouse that display defects in ovarian, uterine and mammary gland development (Lubahn et al., 1993; Korach et al., 1996) . Taken together, these observations suggest that ERa plays a distinct physiological role in estrogen-mediated signaling.
The functions governed by the estrogen receptor in physiological and pathological events have been found to rely on its ability to crosstalk with a variety of other signaling proteins upon its activation. For example, the c-ErbB2 receptor, intimately linked to breast cancer progression, is known to be when overexpressed an indicator of poor patient prognosis that also correlates with the loss of estrogen receptor function (Newman et al., 2000) and tamoxifen resistance (Gullick et al., 1991; Grunt et al., 1995; Carlomagno et al., 1996; De Placido et al., 1998; Houston et al., 1999) , suggesting that surface and nuclear receptor crosstalk may promote the conversion to an aggressive tumor phenotype. The modulation of multiple cytoplasmic molecules, such as PI3 0 K (Simoncini et al., 2000) , Akt/PKB (Campbell et al., 2001; Hisamoto et al., 2001) , mitogen-activated protein kinase (MAPK) pathways (Migliaccio et al., 1993 (Migliaccio et al., , 1998 Kato et al., 1995; Di Domenico et al., 1996) , and cyclinD1 (Zwijsen et al., 1997; Zwijsen et al., 1998; Castoria et al., 2001) , have also been found to be associated with ERa activation. Evidence further demonstrates that signaling via the c-Src protein tyrosine kinase plays an important role in ER activation (Migliaccio et al., 1993 (Migliaccio et al., , 1998 (Migliaccio et al., , 2000 Di Domenico et al., 1996) . Specifically, c-Src has been found to directly phosphorylate ERa on Y537, promoting its transactivation (Arnold et al., 1995a (Arnold et al., , b, 1997 . Furthermore, ERa signal transduction can be attenuated using Src inhibitors . In addition, c-Src has been found to impinge on DNA proliferation, cell survival pathways and cell cycle progression in response to estrogen (Castoria et al., 2001) .
Given the mammary gland phenotype of the ERKOa mouse, in conjunction with the role of c-Src in ER activation, the above data suggest that c-Src may play an important role in ERa-mediated mammary gland development. To investigate the potential in vivo impact on ERa function, we examined whether the development of a number of hormonally dependent tissues was perturbed in c-Src-deficient mice. The results demonstrate that the mammary gland, uterine and ovarian tissues derived from the c-src-deficient animals displayed a dramatic developmental delay. In addition, we demonstrate that mammary epithelial cells (MECs) from c-src-null mice inefficiently activate a number of signaling pathways in response to estrogen stimulation. Taken together, these observations suggest that c-Src plays a role in modulating the response of a number of tissues to estrogen stimulation.
Results

Requirement for c-Src for normal mammary ductal morphogenesis
Given the potential importance of c-Src in ERa signaling in the mammary epithelium, we investigated whether female mice carrying a disrupted c-src gene exhibited any obvious mammary gland defects. To accomplish this, we performed mammary gland wholemount analyses on virgin female mice between 3 and 10 weeks of age. In contrast to the normal ductal patterning observed in wild-type mice, examination of the c-src-deficient strains revealed a dramatic defect in the development of the ductal tree ( Figure 1a) . Furthermore, the observed ductal branching defect does not appear to be due to the runted nature of the c-src-null phenotype since at 6-10 weeks of age c-src-null mice are equivalent in size when compared to their wild-type littermates. In addition to the dramatic effect on ductal outgrowth, the number of terminal end buds (TEBs) in the c-src-null mouse is significantly less than that found in the wild-type mammary tree even up to 10 weeks (Figure 1a and b) . Taken together, these observations suggest that the mammary defect in the c-src-deficient animal potentially phenocopies the observed ductal defect in ERKOa strains.
Uterine and ovarian phenotype revealed in c-src-null mice
In addition to the mammary ductal phenotype, ERadeficient mice also possess ovarian and uterine defects (Lubahn et al., 1993; Schomberg et al., 1999) . To examine whether c-src-deficient mice possess comparable deficiencies in uterine and ovarian development, we performed both gross and histological analyses of these tissues. Analysis of uteri excised from wild-type ( Figure  2a and c) and c-src-null mice (Figure 2b and d) shows that they are grossly dissimilar at 3 and 6 weeks of age. While the uterus from c-src-null mice appears hypoplastic, the epithelial, myometrial and stromal layers, although reduced in size, are intact (Figure 2e and f). However, unlike the ERKOa mice where the uterus remains underdeveloped, c-src-null uteri can support embryonic development (unpublished observations) (Soriano et al., 1991) .
Histological analysis of ovaries from 4-week-old wildtype mice (Figure 2g and i) displays oocytes at all stages of development from primary oocytes to mature late stage Graafian follicles. In contrast, ovaries from agematched c-src-null mice display only primary and secondary oocytes that do not display any late stage follicular development (Figure 2h and j) . However, c-src-null mice are fertile, suggesting that there is a general delay in the development of the reproductive system that correlates with the loss of the c-Src PTK. Taken together, these observations suggest that the cSrc-deficient animals exhibit a similar but milder range of developmental abnormalities exhibited by the ERadeficient strains.
c-Src-null epithelium exhibit defects in their ability to respond to estrogenic stimulation
The above studies suggest that a functional c-Src is required for normal reproductive development, this being consistent with other studies carried out in tissue culture that suggest that c-Src may play an important role in the MECs capacity to respond to estrogen (Migliaccio et al., 1993; Di Domenico et al., 1996; Castoria et al., 2001) . To further address the importance of c-Src in ERa function, MECs from wild-type and c-src-null mice were cultivated in vitro and their capacity to respond to estrogen stimulation was assessed. Upon estrogen stimulation, wild-type explants display an increase in ERa levels in association with its tyrosine phosphorylation. In contrast, explants derived from the null mammary gland fails to display detectable levels of ER upon estrogen stimulation (Figure 3a and b), these differences not being due to variations in epithelial content as assessed by cytokeratin ( Figure 3c ). Consistent with the above observations, the loss of c-Src is found to negatively impact basal ER mRNA levels in c-src-null MECs (Figure 3d , *Po0.05). In addition, MCF-7 cells expressing a dominant negative version of c-Src (Src251) (Kaplan et al., 1995) displayed reduced levels of ERa ( Figure 3e and f) and tyrosine phosphorylation ( Figure 3g ) in response to estrogen stimulation. These data suggest that c-Src can modulate the ER at both the transcriptional and translational levels. An important consequence of the association between c-Src and ERa is the stimulation of the Ras-MAPK signaling pathway Castoria et al., 1999) . Indeed, wild-type MECs stimulated with estradiol results in an increase in MAPK activity that peaks at 3 h poststimulation and then decreases in a temporally dependent fashion (Figure 4a-c) , while c-srcdeficient cells peak at 9 h poststimulation. These effects can be attenuated by U0126 (Figure 4d and e), suggesting that in c-Src wild-type and null MECs, estrogen stimulation specifically results in MAPK activation.
The induction of cellular arrest with the use of antiestrogens can be rescued with the overexpression of cyclinD1, suggesting that cyclinD1 plays an important role in estrogen-mediated cell cycle progression (Sicinski et al., 1995; Prall et al., 1997 Prall et al., , 1998 . Interestingly, results reveal a lower baseline level of cyclinD1 in the c-src-deficient MECs compared to wild type ( Figure  4f and g). However, in null MECs, cyclinD1 reaches wild-type levels 9 h poststimulation. No significant difference in mRNA levels of cyclinD1 was detected in c-src wild-type versus null samples (Figure 4g ), suggesting that the loss of c-Src negatively affects the stability of cyclinD1 in MECs.
Loss of c-Src results in impaired signaling to protein stabilization and survival pathways.
Evidence has suggested that protein stability may play a role in estrogen-mediated signaling (Nawaz et al., 1999; Lonard et al., 2000) . For example, estrogen stimulation results in IRS-1 stability via GSK3b pathway (Morelli et al., 2003) . To address whether GSK3b activity correlates with our previous data (Figure 3) , where ERa levels decrease in the absence of c-Src, MEC lysates were subjected to immunoblot analysis using a phosphospecific (serine 9) GSK3b antibody, its phosphorylation inversely correlating with GSK3b activity leading to an increase in target protein levels (Stambolic and Figure 2 Uterine and ovarian phenotype in c-src-null mice. Gross morphology of postnatal uterine organs from wild-type (a, c) and c-src-null (b, d) mice at 4 and 6 weeks, respectively. Scale bar, 5 mm. Histological examination by hemotoxylin/eosin of a 4-weekold uterus from wild-type (e) and c-src-null (f) mice. Scale bar, 100 mm. Ovaries were excised for histological examination from virgin wild-type (g, i) and c-src-null mice (h, j) at 4 weeks of age. Scale bar, 100 mm. Primary oocytes (O1), secondary oocytes (O2) and mature Graafian follicles (GF) c-Src and ERa in reproductive development H Kim et al Woodgett, 1994; Frame et al., 2001) (Figure 5a ). Interestingly, c-Src-null MECs display a lower level of GSK3b phosphorylation when compared to wild-type MECs, suggesting that GSK3b activity is greater in c-src-null MECs than what is observed in c-src wild-type MECs.
While evidence points to a role for survival pathways in mammary gland development, specifically via Akt (Hutchinson et al., 2001) , the question of whether c-Src can influence Akt function and thereby modify the mammary gland architecture is unclear. To this end, MECs at various time points stimulated with estrogen were analysed for the activation of Akt (Figure 5b ). In the absence of c-Src, we found that Akt activity was suppressed at all time points relative to wild-type upon estrogen stimulation, suggesting that the mammary gland defect may be influenced by machinery associated with apoptosis and cellular survival mediated by Akt.
Discussion
The ability of mammary epithelial cells to respond to and coordinate with a number of different extracellular cues is thought to play a critical role in normal mammary gland development. Here, we demonstrate that germline ablation of c-Src tyrosine kinase has a dramatic defect on the initial stages of mammary ductal outgrowth, uterine and ovarian development. We also show that the defect correlates with a number of molecular pathways that are perturbed in their capacity to respond to estrogen. Whole-mount analyses of the initial stages of mammary gland development revealed a significant delay in mammary ductal outgrowth that was further associated with a decrease in TEB numbers. We also demonstrate that the c-Src-deficient animals exhibit striking delays in both ovarian and uterine development. Of note, ovaries from c-src-null mice appear slightly larger than its wild-type counterpart. Interestingly, ovaries from ERKOa mice display a cystic and hemorrhagic phenotype that results in the massive hyperemic ovarian structures (Korach, 1994) , somewhat similar to the ovaries derived from the c-src-null mouse. However, we believe the similarities end here, given that the c-src-null mice do reproduce while the ERKOa mice are infertile. Therefore, compensatory mechanisms may be at work in the c-src-null mouse.
In addition to the phenotypic defects in the reproductive organs of c-Src-deficient strains, examination of the capacity of MECs derived from c-Src-null animals to respond to estrogenic stimulation correlate with a requirement for c-Src for an epithelial-specific estrogen response. For example, the loss of c-Src correlates with a decrease in estrogen receptor levels as well as its tyrosine phosphorylation. While it appears that the decrease in estrogen receptor levels work in part at the transcriptional level, a translational and/or post-translational mechanism may also be possible. Specifically, while the transcript levels of ER decrease marginally with the loss of c-Src, the decrease in protein levels appears far more dramatic. Potentially, the signaling events described can be attributed solely on the downregulation of the estrogen receptor by c-Src; however, it is also possible that c-Src plays a more direct role in the signaling pathways investigated which then impact on reproductive function. For example, an increase in GSK3b The decrease in GSK3b phosphorylation may be due to the decrease in Akt activation in the absence of c-Src.
Given that c-Src can activate PI3 0 K/Akt (Datta et al., 1996; Chan et al., 2002) in an estrogen-dependent fashion (Simoncini et al., 2000; Campbell et al., 2001; Hisamoto et al., 2001 ), which in turn can modulate GSK3b, suggests that an increase in GSK3b activity may potentially impact negatively on the estrogen receptor by initiating its ubiquitination. Indeed, in the presence of estrogen, we see a decrease in ERa levels in MCF7Src251 cells. This suggests that while the SH3 and SH2 domains of Src251 moderately stabilizes ER levels given its presence in nonstimulated MCF7Src251 cells, the kinase region appears necessary for the full stability of the ER, potentially by activating the Akt/GSK3b pathway. Previous reports demonstrate that posttranslational events may modulate ER levels, specifically, proteosome inhibitors such as MG132 or lactacysin can block ER degradation, suggesting that an ubiquitin-proteosome pathway can mediate the downregulation of the estrogen receptor (Nawaz et al., 1999) . Furthermore, estrogen receptor levels have been found to fluctuate in a cyclical fashion on estrogen response element (ERE)-containing promoters via proteasomemediated degradation initiated by ubiquitination (Reid et al., 2002; Reid et al., 2003) , and inhibition of either the ubiquitination or proteosomal pathways increase estrogen-mediated responses to ERE-containing genes (Fan et al., 2004) . Interestingly, c-src-null mice still retain their reproductive capacity suggesting that there still remains a functional, albeit low, level of ERa that can sustain reproduction in c-src-null mice. To this end, it appears that c-Src activity plays a key role in regulating estrogen receptor levels, potentially modulated by protein stability via GSK3b activity.
Given the importance of the c-Src kinase in cellular signaling, the possibility exists that other receptor pathways contribute to the reproductive phenotype, which include c-ErbB2 (Andrechek et al., 2004; JacksonFisher et al., 2004) , the fibroblast growth factor receptor (Jackson et al., 1997) , the b-catenin (Tepera et al., 2003) and the Wnt-4/Progesterone receptor pathways (Brisken et al., 2000) . Therefore, while our data suggest that the estrogen receptor pathway is influenced by c-Src, it would not be surprising that multiple mechanisms likely play a part in the generation of the reproductive phenotype. Further analysis on the role of c-Src on these other pathways in reproductive development would be of great interest.
A significant find in characterizing estrogen receptor crosstalk was its ability to impinge on the Ras/MAPK signaling pathway Castoria et al., 1999) . Induction by estrogen leads to the phosphorylation of serine 118 on ERa by MAPK, resulting in ERE binding and transactivation of downstream elements (Joel et al., 1995 (Joel et al., , 1998 Kato et al., 1995; Bunone et al., 1996) . Additionally, c-Src induces ER activation, by phosphorylating tyrosine 537 within the AF-2 region, promoting dimerization (Arnold et al., 1995a (Arnold et al., , b, 1997 . This aspect of estrogen receptor phosphorylation is one that is highly contested. For example, some groups have reported the importance of tyrosine phosphorylation on ER (Migliaccio et al., 1986; Pietras et al., 1995) , while others have suggested otherwise (Denton et al., 1992; Lahooti et al., 1994 Lahooti et al., , 1995 Le Goff et al., 1994) . Indeed, it appears that conversion of Y537 to phenylalanine results in a minimal effect on ER activation (White et al., 1997; Yudt et al., 1999) . While this conflicts with the role of Y537 in ER activation, as well as the general role of c-Src in mediating this phosphorylation event, it is possible that the phosphorylation of Y537, while not critical in estrogen receptor activation, is however involved in other aspects of receptor function.
Previously, it has been reported that the presence of a dominant negative version of Src can negatively affect estrogen-induced DNA synthesis (Castoria et al., 1999) and therefore proliferation. Consistent with this, our observations suggest an inability to maintain basal levels of cyclinD1 in the absence of c-Src. Since there are no significant changes in cyclinD1 mRNA levels, posttranslational mechanisms may regulate cyclinD1. Furthermore, this also suggests that the proliferation capacity of c-Src-null MECs may be compromised, similar to other studies (Castoria et al., 1999) , which taken together suggests that the loss of c-Src influences cell cycle pathways that in turn impinge on normal mammary gland development and potentially on reproductive development in general.
Our work further suggests that cell survival pathways also correlate with the loss of c-Src. Consistent with our observations, it has been previously reported that the p85 subunit of PI3 0 K, which is a known c-Src substrate (Datta et al., 1996; Chan et al., 2002) , couples to the estrogen receptor pathway within the cytoplasm (Simoncini et al., 2000) , consequently leading to the activation of Akt (Campbell et al., 2001; Hisamoto et al., 2001) . Additional observations have suggested that a complex exists between a ligand bound estrogen receptor, c-Src and PI3 0 K resulting in S-phase entry of MCF-7 cells via cyclinD1/cdks upon stimulation with estrogen (Castoria et al., 2001) , supporting our in vitro and in vivo data involving the c-src-null mammary gland. Of note, the decrease in proliferation and activation of survival pathways in a c-src-null background only translates to a developmental delay in the generation of an otherwise functional reproductive system. Nevertheless, these data argue that c-Src may serve as a central node in integrating estrogen-dependent activation of MAPK and PI3 0 K signaling pathways in reproductive development.
Previous analysis of other signaling molecules further demonstrates that a dynamic interplay exists to control epithelial cell function. For example, EGFR and estrogen receptor function is absolutely necessary in the stroma to induce estrogen-dependent ductal outgrowth (Wiesen et al., 1999) (Cunha et al., 1997) . Currently it is unclear as to which compartment is necessary for c-Src function; however, to address this question, reciprocal transplant analyses of mammary tissues as well as a tissue-specific ablation of c-src within the epithelial compartment are currently underway. Estrogenic conditions therefore appear to activate c-Src and MAPKs, resulting in transactivation of ERE-containing genes that can influence epithelial cell growth and development.
Materials and methods
Mouse models, primary tissue cultures and stimulations
The derivation of the c-src-null mouse was described previously (Soriano et al., 1991) . Analysis of all wild-type and c-src-null mice, tissues and cell cultures derived from these mice were in the context of an Fvb/n genetic background, backcrossed over 10 generations from its original genetic background (Soriano et al., 1991) . The MCF7 and the MCF7Src251 cell lines were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) with penicillin, streptomycin and amphotercin-B. For MEC studies, the whole c-Src and ERa in reproductive development H Kim et al inguinal mammary gland of virgin female Fvb/n mice was excised and dissected into small fragments. With the addition of an equal volume of PBS and 2 Â collagenase/dispase solution (0.05 g collagenase; 0.5 g dispase; 100 ml of PBS), the tissue was incubated at 371C under constant agitation. The solution was cleared and the pellet was resuspended in DMEM supplemented with 10% FBS/penicillin/streptomycin/ amphotercin-B.
To stimulate with estradiol (E2, Calbiochem), cells were incubated with 100 nM of E2 for the required times. Serum starvation of cells consisted of incubation with DMEM supplemented with 0.5% FBS. Stripping of endogenous lactogens was performed as described (Lippman et al., 1976; Biswas and Vonderhaar, 1987) . For U0126 inhibition (New England Biolabs), cells were exposed to 10 mM of the inhibitor in combination with 100 nM of E2 over the described time course.
Expression constructs and protein analysis
The c-Src251 construct was described previously (Kaplan et al., 1995) , representing a truncated version of c-Src at amino acid 251. Adherent cells were washed twice in ice-cold 1 Â PBS supplemented with 1 mM sodium orthovanadate. Cell lysis was in 50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM EGTA, 1.5 mM MgCl 2 , 10mM NaF, 10 mM sodium pyrophosphate, 10 mg/ml leupeptin and 10 mg/ ml aprotinin. Each lysate was cleared by centrifugation and quantitated by Bradford assay as specified by the manufacturer (Biorad). Antibodies used include anti-Src (v-Src Ab1, Oncogene Science), anti-phosphotyrosine (PY20, Transduction Labs), anti-Estrogen receptor (Calbiochem); anti-(p)MAPK and MAPK (New England Biolabs); anti-(p)Akt and Akt (New England Biolabs); anti-(p) GSK3a/b and GSK3b (New England Biolabs); anti-CyclinD1 (Santa Cruz) and anti-cytokeratin AE3 (Biomeda). Immunoprecipitation analysis was performed as previously described (Dankort et al., 1997) .
RNA analysis and quantitative PCR
Flash-frozen tissue was prepared using the reagent TRIZOL s (GibcoBRL). RNA samples were isolated as per the manufacturer's instructions. Using a fluorescence-based method (LightCyclert, Roche), each reaction was set up under the following conditions: CyclinD1 7 mM MgCl 2 , 0.5 mM primers, 200ng of RNA; ERa 5 mM MgCl 2 ; 0.3 mM primers, 400 ng RNA; PGK 6 mM MgCl 2 , 0.5 mM primers. Conditions were optimized for each primer pair such that one specific melting curve was obtained. Quantitation was performed using LightCycler v1.2 software. Murine Estrogen receptor a forward 5 0 -ACACGTTTCTGTCCAGCACC-3 0 , reverse 5 0 -GCCTTTGT TACTCATGTGCC-3 0 ; mCyclinD1 forward 5 0 -CCCGCTGG CCATGAACTAC-3 0 , reverse 5 0 -GTGTGTGCATGCTTGC GG-3 0 ; mPGK forward 5 0 -CACAGAGGATAAAGTCAG CC-3 0 , reverse 5 0 -ATAGACGCCCTCTACAATGC-3 0 .
Mammary gland analysis
The inguinal gland was prepared as previously described (Webster et al., 1995) .
Statistics mRNA levels are standardized against mPGK as an internal control and normalized to T 0 . Results are presented as mean7s.e.m. Student's t-test was used to evaluate the statistical significance (defined as Po0.05).
